Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B-Reference-Cited by-同舟云学术

Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B

Published:2011-09-07 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Iorio Alfonso¹,Marchesini Emanuela²,Marcucci Maura²,Stobart Kent³,Chan Anthony KC⁴

Affiliation:

1. McMaster University; Clinical Epidemiology and Biostatistic Department; 1280 Main Street West CRL - 140 Hamilton ON Canada L8S 4K1

2. University of Perugia; Department of Internal Medicine; Ospedale Santa Maria della Misericordia Località Sant'Andrea delle Fratte Perugia Italy 06126

3. University of Alberta; Northern Alberta Children's Cancer Program, Department of Pediatrics; Room 7327A Aberhart Centre 11402 University Avenue NW Edmonton Alberta Canada T6G 2J3

4. McMaster University; Division of Pediatric Hematology/Oncology, Health Sciences Centre; 1200 Main Street West Hamilton Ontario Canada L8N 3Z5

Publisher

Wiley

Subject

Pharmacology (medical)

Reference57 articles.

1. Prophylaxis in hemophilia: a double-blind controlled trial;Aronstam;British Journal of Haematology,1976

2. Twice weekly prophylactic therapy in haemophilia A;Aronstam;Journal of Clinical Pathology,1977

3. Improved cost-effectiveness by pharmacokinetic dosing of factor VIIII in prophylactic treatment of haemophilia A;Carlsson;Haemophilia,1997

4. A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study);Gringeri;Journal of Thrombosis and Haemostasis,2011

5. Central venous access device infections in children with hemophilia;Hacker;Journal of Pediatric Hematology/Oncology,2007

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art;Bleeding, Thrombosis and Vascular Biology;2024-09-04

2. Clinical data on treatment regimen and use of medication among patients with hemophilia B in Korea;Blood Research;2024-08-08

3. Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A;Haemophilia;2024-07-10

4. Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients with Haemophilia B Without Inhibitors;Advances in Therapy;2024-04-23

5. How much prophylaxis is enough in haemophilia?;Haemophilia;2024-03-24